Total Liabilities for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported total liabilities is $2.18B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$2.18B
YoY change
+9.9%
5Y CAGR
+1.1%
Peak year (2023)
$2.62B
Latest annual
$2.21B
Total Liabilities history chart for ResMed (RMD) from 1993 to 2025
Total Liabilities history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $2.21B | +9.9% | ||
| 2024 | $2.01B | -23.4% | ||
| 2023 | $2.62B | +51.1% | ||
| 2022 | $1.74B | -5.8% | ||
| 2021 | $1.84B | -11.9% | ||
| 2020 | $2.09B | +2.7% | ||
| 2019 | $2.04B | +102.5% | ||
| 2018 | $1.00B | -33.4% | ||
| 2017 | $1.51B | -3.4% | ||
| 2016 | $1.56B | +162.7% | ||
| 2015 | $594.47M | -1.4% | ||
| 2014 | $602.71M | +0.4% | ||
| 2013 | $600.21M | +13.2% | ||
| 2012 | $530.24M | +56.8% | ||
| 2011 | $338.19M | -0.2% | ||
| 2010 | $338.86M | -13.7% | ||
| 2009 | $392.78M | +21.1% | ||
| 2008 | $324.23M | +1.1% | ||
| 2007 | $320.82M | +19.2% | ||
| 2006 | $269.07M | -10.3% | ||
| 2005 | $300.08M | +59.9% | ||
| 2004 | $187.65M | +8.4% | ||
| 2003 | $173.16M | -5.5% | ||
| 2002 | $183.26M | -2.4% | ||
| 2001 | $187.72M | +768.2% | ||
| 2000 | $21.62M | +18.2% | ||
| 1999 | $18.29M | +32.5% | ||
| 1998 | $13.80M | +34.0% | ||
| 1997 | $10.30M | +24.1% | ||
| 1996 | $8.30M | +29.7% | ||
| 1995 | $6.40M | +60.0% | ||
| 1994 | $4.00M | +73.9% | ||
| 1993 | $2.30M | — |
Total Liabilities values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
ResMed (RMD) most recent annual total liabilities stands at $2.21B (2025) – grew 9.9% year-over-year.
ResMed total liabilities compound annual growth for the 2020–2025 (5 years) window is +1.1%, with the latest reading among the more recent periods of the dataset.
$2.62B stands as the all-time-high annual total liabilities, posted in 2023, against a low of $2.30M during 1993.
Within Healthcare, ResMed (RMD) ranks 9th among 8 peers we track. The peer median for total liabilities is $101.80B.
ResMed Total Liabilities by Year
ResMed Total Liabilities 2025: $2.21B
ResMed total liabilities in 2025 was $2.21B, grew 9.9% from 2024.
ResMed Total Liabilities 2024: $2.01B
ResMed total liabilities in 2024 was $2.01B, declined 23.4% below 2023.
ResMed Total Liabilities 2023: $2.62B
ResMed total liabilities in 2023 was $2.62B, surged 51.1% from 2022. This figure represents the highest annual value in the available history.
ResMed Total Liabilities 2022: $1.74B
ResMed total liabilities in 2022 was $1.74B, declined 5.8% below 2021.
ResMed Total Liabilities 2021: $1.84B
ResMed total liabilities in 2021 was $1.84B.
See more financial history for ResMed (RMD).
Sector peers — Total Liabilities
Companies in the same sector as ResMed, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is ResMed's total liabilities?
- Latest reported total liabilities for ResMed (RMD) is $2.18B (period ending December 31, 2025).
How has ResMed total liabilities changed year-over-year?
- ResMed (RMD) total liabilities changed +9.9% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed total liabilities?
- ResMed (RMD) total liabilities compound annual growth rate is +1.1% over the most recent 5 years available.
When did ResMed total liabilities hit its highest annual value?
- ResMed total liabilities reached its highest annual value of $2.62B in 2023.
What was ResMed total liabilities in 2024?
- ResMed (RMD) total liabilities in 2024 was $2.01B.
What was ResMed total liabilities in 2025?
- ResMed (RMD) total liabilities in 2025 was $2.21B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.